DD

Active Director Director DIN 09129131
DIN 09129131 First appointment Apr 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value •••• Premium profile

About Dev Datt

Data last updated:

Dev Datt is a Director at Biodeal Pharmaceuticals Limited (since 2021). The company operates in Pharma. Biodeal Pharmaceuticals Limited reported revenue of ₹209 Cr (FY 2025).

DIN 09129131
Primary Designation Director
Industry Pharma
First Appointment 01 Apr 2021
Oldest Company Age 20 yrs
Largest company Biodeal Pharmaceuticals Limited · ₹209 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biodeal Pharmaceuticals Limited U00304HP2005PLC029451
Director01 Apr 20212005₹209 Cr (FY 2025)Active

Board colleagues of Dev Datt

Directorship timeline

Open interactive timeline →
Biodeal Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Dev Datt

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dev Datt

Dev Datt currently holds 1 directorship: Biodeal Pharmaceuticals Limited (Director, since 01 Apr 2021, revenue ₹209 Cr (FY 2025)).

Dev Datt was first appointed on 01 Apr 2021 as Director at Biodeal Pharmaceuticals Limited.

The current boards of Dev Datt's companies include Abhishek Jain (Biodeal Pharmaceuticals Limited), Adheesh Chander Malhotra (Biodeal Pharmaceuticals Limited), Anchal Kumari (Biodeal Pharmaceuticals Limited), Anurag Kumar (Biodeal Pharmaceuticals Limited), Noopur Jha (Biodeal Pharmaceuticals Limited), Rishi Kapoor (Biodeal Pharmaceuticals Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available